Validation of the Oxford Participation and Activities Questionnaire

Abstract

PurposeThere is growing interest in the management of long-term conditions and in keeping people active and participating in the community. Testing the effectiveness of interventions that aim to affect activities and participation can be challenging without a well-developed, valid, and reliable instrument. This study therefore aims to develop a patient-reported outcome measure, the Oxford Participation and Activities Questionnaire (Ox-PAQ), which is theoretically grounded in the World Health Organization’s International Classification of Functioning, Disability, and Health (ICF) and fully compliant with current best practice guidelines.MethodsQuestionnaire items generated from patient interviews and based on the nine chapters of the ICF were administered by postal survey to 386 people with three neurological conditions: motor neuron disease, multiple sclerosis, and Parkinson’s disease. Participants also completed the Medical Outcomes Study (MOS) 36-Item Short Form Health Survey (SF-36) and EQ-5D-5L.ResultsThus, 334 participants completed the survey, a response rate of 86.5%. Factor analysis techniques identified three Ox-PAQ domains, consisting of 23 items, accounting for 72.8% of variance. Internal reliability for the three domains was high (Cronbach’s α: 0.81–0.96), as was test–retest reliability (intraclass correlation: 0.83–0.92). Concurrent validity was demonstrated through highly significant relationships with relevant domains of the MOS SF-36 and the EQ- 5D-5L. Assessment of known-groups validity identified significant differences in Ox-PAQ scores among the three conditions included in the survey.ConclusionResults suggest that the Ox-PAQ is a valid and reliable measure of participation and activity. The measure will now be validated in a range of further conditions, and additional properties, such as responsiveness, will also be assessed in the next phase of the instrument’s development.

Deep Brain Stimulation Impact on Social and Occupational Functioning in Parkinson's Disease with Early Motor Complications

“…Importantly, discrepancies between patient‐reported and physician‐reported treatment effects and the importance of determining the latter from the patient's perspective versus the physician's subjective interpretation have long been recognized 38 . Further work on assessing the societal impact of DBS should also consider the recent suggestion to assess broader concepts of “participation” in society beyond the ability to work to fully capture the societal impact of disease and treatments 39,40 …”

Predictors of activity and participation across neurodegenerative conditions: a comparison of people with motor neurone disease, multiple sclerosis and Parkinson’s disease

“…This was a cross-sectional, postal survey that formed the basis of a previously reported validation study [ 15 ]. The Medical Sciences Inter Divisional Research Ethics Committee of the University of Oxford granted ethical approval for the validation work undertaken (reference MSD-IDREC-C1-2014-089).…”

Timely relapse treatment in multiple sclerosis: health utility analysis of the NeuroDirect integrated pathway

“…It is the recommended generic tool to assess health technologies, health services used to prevent and treat diseases (NICE, 2008). Indeed, EQ5D-5L been shown to be a reliable generic psychometric tool for other medical conditions such as type 2 diabetes (Koh et al, 2016, Cheung et al, 2016, and it is currently used as a standard for the development of new disease-specific psychometric tools (Hill et al, 2016, Morley et al, 2016.…”